Accumulation of nitidine chloride in rat heart and the underlying mechanism

LI Cui1,2 CHEN Ying-chun2 ZENG Qing-quan2 LEI Shao-wei1,2 ZHOU Hui2 JIANG Hui-di2 LI Li-ping2

(1.Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China 310014)
(2.Laboratory of Pharmaceutical Analysis and Drug Metabolism, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China 310058)

【Abstract】Nitidine chloride (NC) is a compound with prominent antitumor activity. To determine the potential cardiotoxicity of NC, this study was designed to investigate the distribution of NC in rat heart and the underlying mechanisms. The animal studies were approved by Institutional Animal Care and Use Committee of Zhejiang University Medical Center (2015-380-01) and were complied with the standards of animal welfare in China. At the 0.25th, 0.5th, and 2nd hour after a single intravenous injection (iv) of 5 mg·kg−1 NC, the concentration of NC in rat heart was 47.7 μg·g−1, 71.1 μg·g−1, and 63.2 μg·g−1, respectively, which was 576-fold, 1 352-fold, and 1 212-fold of that in the plasma. Our study also revealed that the NC concentration in heart was 458.5 μg·g−1 (7 336-fold of that in plasma) 2 h after the last dose in rats, after daily iv of NC at 5 mg·kg−1·d−1 for 20 successive days. Further studies showed that the accumulation of NC in MDCK-hOCT1 and MDCK-hOCT3 cells was 16.1-fold and 4.99-fold of that of the mock cells, respectively. There was no significant difference between the accumulation of NC in MDCK cells transfected with hOCTN1, hOCTN2, or hPMAT and the mock cells. Additionally, quinidine, L-tetrahydropal‐matine (L-THP) and Decynium 22, the inhibitors of OCTs, significantly decreased the accumulation of NC in primary myocardial cells and cardiac fibroblasts from neonatal rats. The results of MTT assay showed that the LC50 of NC on myocardial cells and cardiac fibroblasts was 10.9 and 10.4 μmol·L−1, respectively. Moreover, treatment of the primary myocardial cells and cardiac fibroblasts with NC (1–15 μmol·L−1) for 48 h resulted in significantly increased leakage of LDH in these cells. The results above indicated that NC could be highly accumulated in the heart, and that the accumulation was mediated by OCT1 and OCT3, but not by OCTN1, OCTN2, or PMAT. The accumulated NC had potential cytotoxicity to the primary myocardial cells and cardiac fibroblasts.

【Keywords】 nitidine chloride; cardiac accumulation; organic cation transporter 1 and 3 (OCT1, OCT3) ; cardiotoxicity;

【Funds】 National Natural Science Foundation of China (81872929) Natural Science Foundation of Zhejiang Province (LY19H310005)

Download this article

(Translated by XING Y)


    [1] Yang XF, Lu XS. Using HPLC method to determine the content of the two side of chloride in the tri-ninth gastric granules [J]. Chin J Ethnomed Ethnopharm, 2017, 26: 25–27.

    [2] Li LP, Tu MJ, Yang X, et al. The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity [J]. Drug Metab Dispos, 2014, 42: 1227–1234.

    [3] Chen SP, Yang L, Feng J. Nitidine chloride inhibits proliferation and induces apoptosis in ovarian cancer cells by activating the Fas signalling pathway [J]. J Pharm Pharmacol, 2018, 70: 778–786.

    [4] Liu LM, Xiong DD, Lin P, et al. DNA topoisomerase 1 and 2 A function as oncogenes in liver cancer and may be direct targets of nitidine chloride [J]. Int J Oncol, 2018, 53: 1897–1912.

    [5] Huan HL, Liu HG, Meng Y, et al. Effect of nitidine chloride on the heart development of zebra fish embryos [J]. Guangxi Med J, 2011, 33: 546–548.

    [6] Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications [J]. Pharm Res, 2007, 24: 1227–1251.

    [7] Barnes K, Dobrzynski H, Foppolo S, et al. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH [J]. Circ Res, 2006, 99: 510–519.

    [8] Tu MJ, Sun SY, Wang K, et al. Organic cation transporter 1mediates the uptake of monocrotaline and plays a key role in its hepatotoxicity [J]. Toxicology, 2013, 311: 225–230.

    [9] Sun SY, Wang K, Lei HM, et al. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2014, 49: 1–6.

    [10] Weng YY, Jin LS, Wang YQ, et al. Establishment and application of cell models with stable expression of hOCTN1/2 [J]. Acta Pharm Sin, 2016, 51: 931–937.

    [11] Sun SY, Zhou SS, Lei SW, et al. Jatrorrhizine reduces 5-HT and NE uptake via inhibition of uptake-2 transporters and produces antidepressant-like action in mice [J]. Xenobiotica, 2018. DOI: 10.1080/00498254.2018.1542188.

    [12] Louch WE, Sheehan KA, Wolska BM. Methods in cardiomyocyte isolation, culture, and gene transfer [J]. J Mol Cell Cardiol, 2011, 51: 288–298.

    [13] Li LP, Song FF, Weng YY, et al. Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride [J]. Br JPharmacol, 2016, 173: 2543–2554.

    [14] Wagner DJ, Hu T, Wang J. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics [J]. Pharmacol Res, 2016, 111: 237–246.

    [15] Grube M, Ameling S, Noutsias M, et al. Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy [J]. Am J Pathol, 2011, 178: 2547–2559.

    [16] Bourdet DL, Pritchard JB, Thakker DR. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) [J]. J Pharmacol Exp Ther, 2005, 315: 1288–1297.

    [17] Hayer-Zillgen M, Brüss M, Bönisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 [J]. Br J Pharmacol, 2002, 136: 829–836.

    [18] Krishnamurthy K, Vedam K, Kanagasabai R, et al. Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1) -based drug extrusion in the heart [J]. Proc Natl Acad Sci U S A, 2012, 109: 9023–9028.

    [19] Dazert P, Meissner K, Vogelgesang S, et al. Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart [J]. Am J Pathol, 2003, 163: 1567–1577.

    [20] Doherty KR, Wappel RL, Talbert DR, et al. Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human myocardial cells [J]. Toxicol Appl Pharmacol, 2013, 272: 245–255.

    [21] Li XH, Tang NF, Li YQ, et al. Cytoprotective effect of p62/Nrf2 signaling pathway [J]. Acta Pharm Sin, 2018, 53: 1995–2005.

    [22] Planavila A, Redondo-Angulo I, Ribas F, et al. Fibroblast growth factor 21 protects the heart from oxidative stress [J]. Cardiovasc Res, 2015, 106: 19–31.

    [23] Rossato LG, Costa VM, de Pinho PG, et al. Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated myocardial cells [J]. Arch Toxicol, 2011, 85: 929–939.

This Article


CN: 11-2163/R

Vol 54, No. 05, Pages 913-918

May 2019


Article Outline


  • Materials and methods
  • Results
  • Discussion
  • References